Ecofibre Ltd - Asset Resilience Ratio

Latest as of December 2024: 6.67%

Ecofibre Ltd (EOF) has an Asset Resilience Ratio of 6.67% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Ecofibre Ltd total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

AU$3.87 Million
≈ $2.74 Million USD Cash + Short-term Investments

Total Assets

AU$58.04 Million
≈ $41.07 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2017–2024)

This chart shows how Ecofibre Ltd's Asset Resilience Ratio has changed over time. See EOF book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Ecofibre Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Ecofibre Ltd.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents AU$3.87 Million 6.67%
Short-term Investments AU$0.00 0%
Total Liquid Assets AU$3.87 Million 6.67%

Asset Resilience Insights

  • Limited Liquidity: Ecofibre Ltd maintains only 6.67% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Ecofibre Ltd Industry Peers by Asset Resilience Ratio

Compare Ecofibre Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Jiangsu Hengrui Medicine Co Ltd
SHG:600276
Drug Manufacturers - Specialty & Generic 0.16%
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
Drug Manufacturers - Specialty & Generic 1.54%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
Drug Manufacturers - Specialty & Generic 0.20%
Regencell Bioscience Holdings Ltd
NASDAQ:RGC
Drug Manufacturers - Specialty & Generic 43.05%
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
Drug Manufacturers - Specialty & Generic 20.44%
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755
Drug Manufacturers - Specialty & Generic 24.59%
Henan Newland Pharmaceutical Co. Ltd. A
SHE:301277
Drug Manufacturers - Specialty & Generic 31.63%
Hainan Shuangcheng Pharmaceut
SHE:002693
Drug Manufacturers - Specialty & Generic 3.29%

Annual Asset Resilience Ratio for Ecofibre Ltd (2017–2024)

The table below shows the annual Asset Resilience Ratio data for Ecofibre Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-06-30 0.28% AU$200.00K
≈ $141.51K
AU$71.25 Million
≈ $50.41 Million
-0.01pp
2023-06-30 0.29% AU$347.00K
≈ $245.52K
AU$118.73 Million
≈ $84.01 Million
-4.69pp
2022-06-30 4.99% AU$7.46 Million
≈ $5.28 Million
AU$149.55 Million
≈ $105.82 Million
+1.97pp
2021-06-30 3.02% AU$4.28 Million
≈ $3.03 Million
AU$141.75 Million
≈ $100.29 Million
-10.29pp
2020-06-30 13.31% AU$11.22 Million
≈ $7.94 Million
AU$84.30 Million
≈ $59.64 Million
-35.74pp
2019-06-30 49.05% AU$23.43 Million
≈ $16.58 Million
AU$47.77 Million
≈ $33.80 Million
+24.59pp
2018-06-30 24.46% AU$2.76 Million
≈ $1.95 Million
AU$11.27 Million
≈ $7.97 Million
-15.83pp
2017-06-30 40.29% AU$2.45 Million
≈ $1.73 Million
AU$6.08 Million
≈ $4.30 Million
--
pp = percentage points

About Ecofibre Ltd

AU:EOF Australia Drug Manufacturers - Specialty & Generic
Market Cap
$5.36 Million
AU$7.58 Million AUD
Market Cap Rank
#28208 Global
#1542 in Australia
Share Price
AU$0.02
Change (1 day)
+0.00%
52-Week Range
AU$0.02 - AU$0.02
All Time High
AU$3.79
About

Ecofibre Limited, together with its subsidiaries, engages in the polymer, health care, and hemp seed genetics businesses in the United States and Australia. The company operates through Ecofibre Advanced Technologies, Ananda Health, Ecofibre Genetics, and EOF Bio segments. It offers cannabinoid based health products for human and pet consumption. In addition, the company provides yarn, polymer te… Read more